These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10506724)

  • 1. Survival of patients with high grade glioma treated with intrathecal thiotriethylenephosphoramide for ependymal or leptomeningeal gliomatosis.
    Witham TF; Fukui MB; Meltzer CC; Burns R; Kondziolka D; Bozik ME
    Cancer; 1999 Oct; 86(7):1347-53. PubMed ID: 10506724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal thiotepa: reappraisal of an established therapy.
    Fisher PG; Kadan-Lottick NS; Korones DN
    J Pediatr Hematol Oncol; 2002 May; 24(4):274-8. PubMed ID: 11972095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of preoperative FLAIR MRI and ependymal proximity of tumor enhancement as surrogate markers of brain tumor origin.
    Smith TR; Hulou MM; Abecassis J; Das S; Chandler JP
    J Clin Neurosci; 2015 Sep; 22(9):1397-402. PubMed ID: 26055954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal chemotherapy with ACNU in a meningeal gliomatosis rat model.
    Yoshida TK; Shimizu K; Koulousakis A; Sturm V
    J Neurosurg; 1992 Nov; 77(5):778-82. PubMed ID: 1403122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
    Singh E; Gurses ME; Costello MC; Berke C; Lu VM; Daggubati L; Komotar RJ; Ivan ME; Shah AH
    J Neurooncol; 2024 Mar; 167(1):39-47. PubMed ID: 38294637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to intrathecal infusions of Depocyt® in secondary diffuse leptomeningeal gliomatosis. A case report.
    Beauchesne P; Blonski M; Brissart H
    In Vivo; 2011; 25(6):991-3. PubMed ID: 22021694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
    Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptomeningeal metastasis from supratentorial malignant gliomas.
    Awad I; Bay JW; Rogers L
    Neurosurgery; 1986 Aug; 19(2):247-51. PubMed ID: 3748352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of leptomeningeal malignancy.
    Pentheroudakis G; Pavlidis N
    Expert Opin Pharmacother; 2005 Jun; 6(7):1115-25. PubMed ID: 15957966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal chemotherapy with ACNU for meningeal gliomatosis.
    Yoshida TK; Beuls E; Shimizu K; Koulousakis A; Sturm V
    Br J Cancer; 1992 Dec; 66(6):999-1004. PubMed ID: 1457369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
    Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
    Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary diffuse leptomeningeal gliomatosis with signs of increased intracranial pressure and progressive meningeal enhancement on MRI.
    Park JS; van den Noort S; Kim RC; Walot I; Licht H
    J Neuroimaging; 1996 Oct; 6(4):250-4. PubMed ID: 8903081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging response in malignant glioma, RTOG 90-06.
    Lustig RA; Seiferheld W; Berkey B; Yung AW; Scarantino C; Movsas B; Jones CU; Simpson JR; Fishbach J; Curran WJ
    Am J Clin Oncol; 2007 Feb; 30(1):32-7. PubMed ID: 17278892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain magnetic resonance imaging after high-dose chemotherapy and radiotherapy for childhood brain tumors.
    Spreafico F; Gandola L; Marchianò A; Simonetti F; Poggi G; Adduci A; Clerici CA; Luksch R; Biassoni V; Meazza C; Catania S; Terenziani M; Musumeci R; Fossati-Bellani F; Massimino M
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1011-9. PubMed ID: 17904307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinicopathological study of the spinal leptomeningeal dissemination from cerebral malignant gliomas without a recurrence of the primary lesions].
    Nakagawa K; Sasaki S; Hatakeyama T; Nishihara J; Matuoka K
    Gan No Rinsho; 1990 Jan; 36(1):57-65. PubMed ID: 2153848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pontine glioblastoma multiforme initially presenting with leptomeningeal gliomatosis.
    Motoyama Y; Ogi S; Nabeshima S
    Neurol Med Chir (Tokyo); 2002 Jul; 42(7):309-13. PubMed ID: 12160312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intrathecal ACNU against malignant leptomeningeal tumors--toxicity and therapeutic effect in experimental animals].
    Nagatani M; Arita N; Ushio Y; Hayakawa T; Tzuu-Yuan H; Yoshimine T; Mori S; Mogami H
    No To Shinkei; 1986 Nov; 38(11):1071-5. PubMed ID: 3468960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leptomeningeal gliomatosis. 2 clinicopathological cases].
    Fayet G; Bertout-Lemercier C; Gugenheim M; Auffray E; Jardel-Bouissière J; Lacroix C; Cuillière P; Lhuillier de Cordoze M; Fève JR
    Rev Neurol (Paris); 1994 Oct; 150(10):700-3. PubMed ID: 7792477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal N, N', N"-triethylenethiophosphoramide [thio-TEPA (NSC 6396)] in the treatment of malignant meningeal disease: phase I-II study.
    Gutin PH; Weiss HD; Wiernik PH; Walker MD
    Cancer; 1976 Oct; 38(4):1471-5. PubMed ID: 825215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.
    Wasserstrom WR; Glass JP; Posner JB
    Cancer; 1982 Feb; 49(4):759-72. PubMed ID: 6895713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.